Computational Biology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Tool, By Service, By End User, By Region & Competition, 2021-2031F

Description

The Global Computational Biology Market will grow from USD 5.74 Billion in 2025 to USD 9.13 Billion by 2031 at a 8.04% CAGR. Computational biology serves as a pivotal field that utilizes algorithms, mathematical models, and statistical techniques to analyze and interpret complex biological data.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 5.74 Billion
Market Size 2031	USD 9.13 Billion
CAGR 2026-2031	8.04%
Fastest Growing Segment	Industry and Commercials
Largest Market	North America

Key Market Drivers

Integration of Artificial Intelligence and Machine Learning is fundamentally reshaping the Global Computational Biology Market by expediting the identification of viable therapeutic candidates. Advanced algorithms and generative models can now predict protein structures and optimize molecular designs with unprecedented speed, significantly reducing the time and capital required for preclinical research. This transformative potential has triggered substantial industrial consolidation and capital flow into AI-driven biotech firms.

Key Market Challenges

Data privacy and security concerns constitute a formidable barrier to the expansion of the global computational biology market. This field relies fundamentally on the aggregation and analysis of massive datasets containing sensitive genomic and clinical information, making patient confidentiality paramount. The risk of unauthorized access compels research institutions and pharmaceutical companies to implement restrictive data governance policies. These rigid protocols often result in data silos where valuable biological information remains isolated within a single organization rather than being shared across collaborative research networks.

Key Market Trends

Adoption of Digital Twins for In Silico Clinical Trials is revolutionizing the validation phase of pharmaceutical development by creating virtual patient models to simulate biological responses. This approach addresses the inefficiency of traditional randomized control trials by allowing researchers to generate synthetic control arms, thereby reducing the need for recruiting large numbers of human participants for placebo groups.

Key Market Players

Dassault Systemes SE
Certara Inc
Chemical Computing Group ULC
Compugen Ltd
Rosa & Co. LLC
GeneData AG
Insilico Biotechnology AG
Instem PLC
Strand Life Sciences Pvt Ltd
Schrodinger Inc

Report Scope:

In this report, the Global Computational Biology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Computational Biology Market, By Application:

Cellular and Biological Simulation
Drug Discovery and Disease Modelling
Preclinical Drug Development
Clinical Trials
Human Body Simulation Software

Computational Biology Market, By Tool:

Databases
Infrastructure (Hardware)
Analysis Software and Services

Computational Biology Market, By Service:

In-house
Contract

Computational Biology Market, By End User:

Academics
Industry and Commercials

Computational Biology Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Computational Biology Market.

Available Customizations:

Global Computational Biology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Computational Biology Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software)
- 5.2.2. By Tool (Databases, Infrastructure (Hardware), Analysis Software and Services)
- 5.2.3. By Service (In-house, Contract)
- 5.2.4. By End User (Academics, Industry and Commercials)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
5.3. Market Map

6. North America Computational Biology Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Tool
- 6.2.3. By Service
- 6.2.4. By End User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Computational Biology Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
    - 6.3.1.2.2. By Tool
    - 6.3.1.2.3. By Service
    - 6.3.1.2.4. By End User
- 6.3.2. Canada Computational Biology Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
    - 6.3.2.2.2. By Tool
    - 6.3.2.2.3. By Service
    - 6.3.2.2.4. By End User
- 6.3.3. Mexico Computational Biology Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application
    - 6.3.3.2.2. By Tool
    - 6.3.3.2.3. By Service
    - 6.3.3.2.4. By End User

7. Europe Computational Biology Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Tool
- 7.2.3. By Service
- 7.2.4. By End User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Computational Biology Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
    - 7.3.1.2.2. By Tool
    - 7.3.1.2.3. By Service
    - 7.3.1.2.4. By End User
- 7.3.2. France Computational Biology Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
    - 7.3.2.2.2. By Tool
    - 7.3.2.2.3. By Service
    - 7.3.2.2.4. By End User
- 7.3.3. United Kingdom Computational Biology Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
    - 7.3.3.2.2. By Tool
    - 7.3.3.2.3. By Service
    - 7.3.3.2.4. By End User
- 7.3.4. Italy Computational Biology Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
    - 7.3.4.2.2. By Tool
    - 7.3.4.2.3. By Service
    - 7.3.4.2.4. By End User
- 7.3.5. Spain Computational Biology Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application
    - 7.3.5.2.2. By Tool
    - 7.3.5.2.3. By Service
    - 7.3.5.2.4. By End User

8. Asia Pacific Computational Biology Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Tool
- 8.2.3. By Service
- 8.2.4. By End User
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Computational Biology Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
    - 8.3.1.2.2. By Tool
    - 8.3.1.2.3. By Service
    - 8.3.1.2.4. By End User
- 8.3.2. India Computational Biology Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
    - 8.3.2.2.2. By Tool
    - 8.3.2.2.3. By Service
    - 8.3.2.2.4. By End User
- 8.3.3. Japan Computational Biology Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
    - 8.3.3.2.2. By Tool
    - 8.3.3.2.3. By Service
    - 8.3.3.2.4. By End User
- 8.3.4. South Korea Computational Biology Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
    - 8.3.4.2.2. By Tool
    - 8.3.4.2.3. By Service
    - 8.3.4.2.4. By End User
- 8.3.5. Australia Computational Biology Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application
    - 8.3.5.2.2. By Tool
    - 8.3.5.2.3. By Service
    - 8.3.5.2.4. By End User

9. Middle East & Africa Computational Biology Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Tool
- 9.2.3. By Service
- 9.2.4. By End User
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Computational Biology Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
    - 9.3.1.2.2. By Tool
    - 9.3.1.2.3. By Service
    - 9.3.1.2.4. By End User
- 9.3.2. UAE Computational Biology Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
    - 9.3.2.2.2. By Tool
    - 9.3.2.2.3. By Service
    - 9.3.2.2.4. By End User
- 9.3.3. South Africa Computational Biology Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application
    - 9.3.3.2.2. By Tool
    - 9.3.3.2.3. By Service
    - 9.3.3.2.4. By End User

10. South America Computational Biology Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Tool
- 10.2.3. By Service
- 10.2.4. By End User
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Computational Biology Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
    - 10.3.1.2.2. By Tool
    - 10.3.1.2.3. By Service
    - 10.3.1.2.4. By End User
- 10.3.2. Colombia Computational Biology Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
    - 10.3.2.2.2. By Tool
    - 10.3.2.2.3. By Service
    - 10.3.2.2.4. By End User
- 10.3.3. Argentina Computational Biology Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application
    - 10.3.3.2.2. By Tool
    - 10.3.3.2.3. By Service
    - 10.3.3.2.4. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Computational Biology Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Dassault Systemes SE
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Certara Inc
15.3. Chemical Computing Group ULC
15.4. Compugen Ltd
15.5. Rosa & Co. LLC
15.6. GeneData AG
15.7. Insilico Biotechnology AG
15.8. Instem PLC
15.9. Strand Life Sciences Pvt Ltd
15.10. Schrodinger Inc